Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | market report | table of contents
Czech Republic Pharmaceuticals and Healthcare Report Q3 2008 (Business Monitor International)
- Market: Healthcare and Medical
- Report Title: Czech Republic Pharmaceuticals and Healthcare Report Q3 2008
- View Report Summary: View Report Summary
- Report Type: Market Report
- Country: Czech Republic
- Number of Pages: 58
Executive Summary 5
Czech Republic Pharmaceuticals And Healthcare Industry SWOT 6
Czech Republic Political SWOT 7
Czech Republic Economic SWOT ...... 7
Czech Republic Business Environment SWOT ..... 8
Pharmaceutical Business Environment Ratings .....9
Table: Central And Eastern Europe Pharmaceutical Business Environment Ratings .. 9
Limits To Potential Returns .... 10
Risks To Realisation Of Returns ...... 10
Czech Republic – Market Summary ...11
Regulatory Regime ....12
Intellectual Property Environment ... 13
Pricing And Reimbursement Issues .. 14
Pharmacy Sector ... 16
Hospital Sector ..... 17
Healthcare Sector . 19
Opposition To Health Fees ..... 22
Research And Development Sector .. 23
Industry Forecast Scenario 24
Overall Market Forecast 24
Table: Czech Republic’s Drug Market Forecast Indicators, 2005-2012 .. 24
Key Growth Factors – Industry . 25
Table: Czech Republic’s Health Expenditure Indicators, 2005-2012 26
Key Growth Factors – Macroeconomic .... 27
Table: Czech Republic – Economic Activity ...... 28
Patented Drug Market Forecast ...... 29
Table: Patented Drugs Market Indicators, 2006-2012 (US$mn unless otherwise stated) ... 30
OTC Market Forecasts .. 31
Table: OTC Drugs Market Indicators, 2005-2012 (US$mn unless otherwise stated) 31
Generics Market Forecasts ..... 32
Table: Czech Republic’s Generics Market Forecast ... 32
Export/Import Forecasts 33
Table: Czech Republic’s Pharmaceutical Trade Indicators, 2005-2012 (US$mn) ..... 33
Other Healthcare Data Forecasts .... 34
Table: Socio-Demographic Indicators ...... 34
Key Risks To BMI’s Forecast Scenario ..... 35
Competitive Landscape .36
Wholesale .. 42
Retail .. 42
Company Monitor 45
Multinational Companies .... 45
AstraZeneca . 45
Bristol-Myers Squibb ..... 46
Sanofi-Aventis 47
Walmark 49
Local Company . 51
Zentiva (incorporating Sicomed) ..... 51
BMI Forecast Modelling .54
How We Generate Our Pharmaceutical Industry Forecasts ..... 54
Pharmaceutical Industry 55
Pharmaceutical Business Environment Ratings Methodology .. 55
Ratings Overview .. 55
Table: Pharmaceutical Business Environment Indicators ... 56
Weighting... 57
Table: Weighting Of Components .... 57
Sources .... 57
Czech Republic Pharmaceuticals And Healthcare Industry SWOT 6
Czech Republic Political SWOT 7
Czech Republic Economic SWOT ...... 7
Czech Republic Business Environment SWOT ..... 8
Pharmaceutical Business Environment Ratings .....9
Table: Central And Eastern Europe Pharmaceutical Business Environment Ratings .. 9
Limits To Potential Returns .... 10
Risks To Realisation Of Returns ...... 10
Czech Republic – Market Summary ...11
Regulatory Regime ....12
Intellectual Property Environment ... 13
Pricing And Reimbursement Issues .. 14
Pharmacy Sector ... 16
Hospital Sector ..... 17
Healthcare Sector . 19
Opposition To Health Fees ..... 22
Research And Development Sector .. 23
Industry Forecast Scenario 24
Overall Market Forecast 24
Table: Czech Republic’s Drug Market Forecast Indicators, 2005-2012 .. 24
Key Growth Factors – Industry . 25
Table: Czech Republic’s Health Expenditure Indicators, 2005-2012 26
Key Growth Factors – Macroeconomic .... 27
Table: Czech Republic – Economic Activity ...... 28
Patented Drug Market Forecast ...... 29
Table: Patented Drugs Market Indicators, 2006-2012 (US$mn unless otherwise stated) ... 30
OTC Market Forecasts .. 31
Table: OTC Drugs Market Indicators, 2005-2012 (US$mn unless otherwise stated) 31
Generics Market Forecasts ..... 32
Table: Czech Republic’s Generics Market Forecast ... 32
Export/Import Forecasts 33
Table: Czech Republic’s Pharmaceutical Trade Indicators, 2005-2012 (US$mn) ..... 33
Other Healthcare Data Forecasts .... 34
Table: Socio-Demographic Indicators ...... 34
Key Risks To BMI’s Forecast Scenario ..... 35
Competitive Landscape .36
Wholesale .. 42
Retail .. 42
Company Monitor 45
Multinational Companies .... 45
AstraZeneca . 45
Bristol-Myers Squibb ..... 46
Sanofi-Aventis 47
Walmark 49
Local Company . 51
Zentiva (incorporating Sicomed) ..... 51
BMI Forecast Modelling .54
How We Generate Our Pharmaceutical Industry Forecasts ..... 54
Pharmaceutical Industry 55
Pharmaceutical Business Environment Ratings Methodology .. 55
Ratings Overview .. 55
Table: Pharmaceutical Business Environment Indicators ... 56
Weighting... 57
Table: Weighting Of Components .... 57
Sources .... 57
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
